Medistim ASA
OSE:MEDI

Watchlist Manager
Medistim ASA Logo
Medistim ASA
OSE:MEDI
Watchlist
Price: 261 NOK 0.77% Market Closed
Market Cap: 4.8B NOK

Medistim ASA
Total Liabilities & Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Medistim ASA
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Medistim ASA
OSE:MEDI
Total Liabilities & Equity
kr575.2m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
11%
Lifecare AS
OSE:LIFE
Total Liabilities & Equity
kr79.2m
CAGR 3-Years
27%
CAGR 5-Years
40%
CAGR 10-Years
N/A
O
Observe Medical ASA
OSE:OBSRV
Total Liabilities & Equity
kr133.5m
CAGR 3-Years
-18%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

Medistim ASA
Glance View

Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.

MEDI Intrinsic Value
195.85 NOK
Overvaluation 25%
Intrinsic Value
Price

See Also

What is Medistim ASA's Total Liabilities & Equity?
Total Liabilities & Equity
575.2m NOK

Based on the financial report for Sep 30, 2025, Medistim ASA's Total Liabilities & Equity amounts to 575.2m NOK.

What is Medistim ASA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
11%

Over the last year, the Total Liabilities & Equity growth was 17%. The average annual Total Liabilities & Equity growth rates for Medistim ASA have been 10% over the past three years , 8% over the past five years , and 11% over the past ten years .

Back to Top